DDC
CSTL icon

DF Dent & Co’s Castle Biosciences CSTL Stock Holding History

DF Dent & Co’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-103,810
Closed -$4.66M – 237
2022
Q1 		$4.66M Buy
103,810
+15,359
+17% +$635K 0.05% 101
2021
Q4 		$3.79M Sell
88,451
-12,109
-12% -$633K 0.04% 108
2021
Q3 		$6.69M Buy
100,560
+6,360
+7% +$448K 0.07% 93
2021
Q2 		$6.91M Buy
94,200
+6,857
+8% +$453K 0.07% 90
2021
Q1 		$5.98M Buy
87,343
+46,591
+114% +$3.5M 0.07% 90
2020
Q4 		$2.74M Buy
+40,752
New +$2.21M 0.03% 105

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

DF Dent & Co's CSTL Position: Q2 2022 in Review

DF Dent & Co sold out of Castle Biosciences (CSTL) in Q2 2022, closing a stake of 103,810 shares — an estimated $4.66M sold.

DF Dent & Co first reported a position in CSTL in Q4 2020 and held it in 6 quarters. The position peaked at $6.91M in Q2 2021. 146 funds tracked by Wall St. Rank hold CSTL as of Q2 2022.

  • DF Dent & Co reported no remaining Castle Biosciences position as of Q2 2022 after selling out during the quarter.
  • DF Dent & Co sold 103,810 Castle Biosciences shares in Q2 2022, an estimated $4.66M.
  • DF Dent & Co first reported a position in Castle Biosciences in Q4 2020 and held it in 6 quarters.
  • DF Dent & Co's Castle Biosciences position peaked at $6.91M in Q2 2021.
  • 146 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2022.

Based on DF Dent & Co's 13F filing for Q2 2022, filed 15 Aug 2022.